NEW MALARIA VACCINES ROADMAP TARGETS NEXT GENERATION PRODUCTS BY 2030 PARTNERS AGREE APPROACH FOR DEVELOPING VACCINES CAPABLE OF REDUCING MALARIA CASES BY 75%, AND TO ENABLE MALARIA ELIMINATION

摘要

WASHINGTON, DC - 14 November 2013. The world should aim to have vaccines which reduce malaria cases by 75%, and are capable of eliminating malaria, licensed by 2030, according to the updated 2013 Malaria Vaccine Technology Roadmap, launched today. This new target comes in addition to the original 2006 Roadmap's goal of having a licensed vaccine against Plasmo-dium falciparum malaria, the most deadly form of the disease, for children under 5 years of age in sub-Saharan Africa by 2015. "Safe, effective, affordable vaccines could play a critical role in defeating malaria," said Dr Robert D. Newman, Director of WHO's Global Malaria Programme. "Despite all the recent progress countries have made, and despite important innovations in diagnostics, drugs and vector control, the global burden of malaria remains unacceptably high."